ICAAC

Switch to desktop

Home

Invited Sessions by Topical Category (2)

View the confirmed invited sessions for the ICAAC 2012 by topical category. A daily schedule will be available at a later date.

View the confirmed invited sessions for the ICAAC 2012 by topical category. A daily schedule will be available at a later date.

A. Antimicrobial Pharmacokinetics, Pharmacodynamics and General Pharmacology

Symposia

  • Vancomycin: What Do We Know Now About Pharmacokinetics/Pharmacodynamics? Pharmacodynamics of Antifungal Agents
  • Targeting Gram-Negative Superbugs with Polymyxins: From Lab-Bench to Bedside
  • Aerosol Drug Delivery: Getting Anti-Infective Agents to the Lung
  • Use of Pharmacokinetics/Pharmacodynamics for Risk Reduction of Adverse Events

Meet-the-Experts

  • Intra- and Extracellular Activities of Anti-Infective Agents
  • Top Papers in Anti-Infective and Antiretroviral PK/PD
  • Surgical Prophylaxis: Dosage Recommendations, Tissue Penetration, and Pharmacokinetic Considerations

 

B. Therapy in Animal Models, Pathogenesis of Infectious Diseases, Molecular Basis for Pathogenicity, and Host Defenses

Symposia

  • Bacterial and Viral Infections in Patients Treated with Novel Biologic Agents: What Do I Need to Know?
  • Malnutrition, Microbiome & Mucosal Immunity
  • New Concepts in Tuberculosis: Pathogenesis, Diagnostics, Treatment, and Prevention
  • Virulence Bags: Extracellular Vesicles that Modify Host-Pathogen Interactions
  • Pathogenesis, Diagnosis and Treatment of Urinary Tract Infections
  • Microbial Factors Modulating Host Responses: New Frontiers

 

C1. Antibacterials: Mechanisms of Action, Biochemistry and Genetics of Resistance (Antibacterial, not Viral or Fungal)

Symposia

  • Bacterial Communication and Resistance
  • Multidrug Resistance in Emerging Countries
  • Resistance in S. aureus Beyond MecA
  • Novel Techniques for the Diagnostic of the Emerging Antibiotic Resistances
  • Plasmid Mediated Quinolone Resistance

Meet-the-Experts

  • Top 10 ß-Lactamase Papers in 2012

 

C2. Antibacterials: Surveys and/or Molecular Epidemiology of Resistance and Resistance Genes, Strains or Serotypes (Bacterial, not Viral or Fungal Resistance)

Symposia

  • Global Spread of Antimicrobial Resistance: Mechanisms of Spread, Surveillance, and Control
  • Antibiotic Combinations Against Gram-Negatives in the XDR Era: From Bench to Bedside
  • Population Dynamics in Streptococcus pneumoniae
  • Whole Genome Sequencing and Molecular Epidemiology: The New Frontier?

Meet-the-Experts

  • Anaerobes and Surveillance: Neglected or Not?
  • Detecting, Controlling, and Treating Carbapenemase-Producing Enterobacteriaceae
  • Surveillance of Antimicrobial Resistance: Potential Sources of Bias
  • Clostridium difficile: The Management of Severe and Recurrent Infections

 

D. Laboratory Tests for Diagnosing Infections; Methods for Antibacterial Susceptibility Testing

Cases in Clinical Microbiology

  • Challenges in the Diagnosis and Clinical Interpretation of Infections with Gram-Positive Rods Symposia
  • Best Practices: Diagnosis of Viral Causes of Hepatitis
  • Antimicrobial Susceptibility Update
  • Epidemiology and Diagnosis of Febrile Illness in the Era of Global Climate Change

Meet-the-Experts

  • Optimal Diagnostic Testing for Clostridium difficile in Clinical Practice
  • Syphilis Diagnostics: Traditional Versus “New” Algorithm
  • MALDI-TOF Mass Spectrometry: Implementation and Impact on Patient Care

 

E. In Vitro Antibacterial Susceptibility Studies and Drug-Combination Interactions

Symposia

  • Selecting Antibiotic Resistant Mutants in the Laboratory: How Best to Mimic the Real World?
  • Origins and Ecology of Antibiotic Resistance
  • Laboratory Approaches for Detection, Characterization, and Reporting of Important Resistance Mechanisms in Gram-Negatives

 

F. New Antimicrobial Agents (i.e. pre-US IND or prior to the start of any clinical therapeutic studies) and New Research Technologies

Meet-the-Experts

  • Meeting the Challenge of Efflux from Gram-Negative Bacteria

Symposia

  • Alternative Approaches to Inhibiting Gram-Negative Bacteria
  • Host Defense (Antimicrobial) Peptides: Major Players in Health and Novel Therapeutics
  • Iron Transport and Homeostasis: Are There Opportunities for New Drugs?
  • New Treatments for Mycobacterium tuberculosis Infections
  • New Approaches in the Treatment of Fungal Infections

 

G. Adult and Pediatric Vaccine Studies and Pediatric Infections

Interactive Symposia

  • Interactive Cases in Pediatric Infectious Diseases

Symposia

  • Vaccine Conquests and Challenges
  • Interplay between Pathogen and Host: From Immune Deficiency to Infectious Disease Vaccine Innovations
  • Hot Topics in Vaccines
  • Hot Topics in Pediatric Infectious Disease: 2012

Meet-the-Experts

  • Antibiotic Shortages, Antibiotic Stewardship and the Sick Child
  • Healthy Mother, Healthy Baby

 

H. HIV/AIDS and Other Retroviruses, Including Resistance

Symposia

  • What’s New in Antiretroviral Therapy
  • Current Issues in HIV-Associated Opportunistic Diseases
  • Update on HIV-Associated Co-Morbidities

Meet-the-Experts

  • Management of Antiretroviral Therapy-Induced Bone Toxicity
  • Prevention of Anal Cancer in HIV-Infection: From Early Detection to Vaccination
  • Can We Safely Simplify Antiretroviral Therapy in Treatment-Experienced Patients?
  • How Do I Treat HCV in HIV/HCV Co-Infected Patients?

 

K. Healthcare-Associated and Surgical Infections and Clinical Epidemiology

Interactive Symposia

  • Evidence-Based Infection Prevention and Control: Answering Key Questions
  • Challenges in Infection Control

Symposia

  • Preventing the Spread of M. tuberculosis in Healthcare Facilities
  • Are Prevalence Surveys Still Useful for Healthcare-Associated Infection Surveillance?
  • A Multifaceted Approach to Preventing Surgical Site Infections

Meet-the-Experts

  • Infection Prevention and Control in Low- and -Middle-Resource Settings
  • Environmental Cleaning and Infection Prevention
  • Preventing Line-Associated Bloodstream Infection: Which Measures are Essential?
  • Top Papers in Infection Prevention and Control: 2011-2012
  • MDRO Control: What to Do When Basic Prevention Measures Don’t Work?
  • Antimicrobial Resistance and Antimicrobial Stewardship in Non-Hospital Settings
  • Challenging Issues in Pediatric Infection Prevention and Control

 

L. Clinical Treatment and Outcome Trials Involving Adult Community-Acquired Infections, Including Obstetrical-Gynecological and Sexually Transmitted Infections

Symposia

  • New Issues in the Management of MDR/XDR TB
  • What Every Clinician Should Know About Emerging New Antimicrobials
  • New Issues in the Management of Multidrug-Resistant (MDR) Endocarditis
  • 50 Years of Fluoroquinolones: Past, Present and Future
  • Dangerous Pets and Other Animals
  • An Update on Streptococcal Pharyngitis and Rheumatic Fever
  • What Every Clinician Should Know About Emerging New Antimicrobials
  • New Issues in the Management of Multidrug-Resistant (MDR) Endocarditis
  • Emerging and Current Challenges
  • An Update on Novel & Important Tickborne Diseases
  • What's New with Pneumococcus?
  • New Insights in Diabetic Foot Infections and Osteomyelitis
  • An Update on the Treatment and Prevention of UTIs
  • An Update on Perinatal Infections

Meet-the-Experts

  • Challenging Infections in Older Adults
  • Difficult to Manage Cutaneous Infections in Adults and Children

 

M. Mycology, Including Resistance and Mechanisms of Action of Antifungals

Interactive Symposium

  • Challenging Cases in Mycology

Symposia

  • Fungal Infections in High-Risk Groups: Current and Future Strategies for Control
  • Mycology 2012: Top Papers
  • Controversies in Clinical Mycology
  • Research in Mycology: Hot Topics

Meet-the-Experts

  • How Can the Mycology Lab Work for You?
  • Fungal Infections of the Central Nervous System
  • Fungal Infections Involving the Eye

 

P. Global Health, Travel Medicine and Parasitology

Interactive Symposia

  • What’s Hot Where it’s Hot: Interactive Cases in Tropical Medicine
  • Clinical Problem Solving in Returned Travelers

Symposia

  • Update on Drug Resistance in Malaria
  • Eradication of Globally Important Infectious Diseases
  • How to Develop Global Health as an Academic Disciple

Meet-the-Experts

  • Controversies in Pre-Travel Medicine
  • Top Ten Papers in Travel Medicine

 

V. Virology (Non-HIV), Including Resistance, and Non-HIV Viral Opportunistic Infections in HIV-Infected Patients

Interactive Symposium

  • Transplantation and the ID Physician: Management Strategies for the 21st Century

Symposia

  • Hot Topics in Viral Hepatitis
  • Influenza: Beyond the Headlines
  • Recognizing and Managing Antiviral Resistance
  • Viruses and the Central Nervous System: Diagnostic, Treatment and Recent Outbreaks

Meet-the-Experts

  • CMV Persistent Viremia: What Does it Mean?
  • New Strategies for Transplantation of HIV-Infected Individuals

 

 

 

American Society For Microbiology © 2012

Top Desktop version